Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
Business
Lauren Almeida

Mounjaro maker wants NHS drug price rises in return for more investment in UK

Pre-filled injection pens of 2.5mg, 5mg and 7.5mg doses of Mounjaro, the tirzepatide weight-loss medication manufactured by the US firm Eli Lilly
Eli Lilly, which makes Mounjaro, was one of several pharmaceutical firms to ditch or pause almost £25bn in investments in the UK last year. Photograph: Niall Carson/PA

The US pharmaceutical group behind the Mounjaro weight-loss drug has said it will unpause its UK investments if ministers agree to regularly increase NHS drug prices and end a rebate scheme.

Patrik Jonsson, the president of Eli Lilly’s international business, said the company was in talks with UK ministers and that he was optimistic about reaching an agreement this summer for Britain to pay more for its medicines.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.